Literature DB >> 6404027

Liver transplantation in the rat. Biochemical and histological evidence of complete tolerance induction in non-rejector strains.

N Kamada, H S Davies, D Wight, L Culank, B Roser.   

Abstract

Orthotopic liver allografts in the rat survive indefinitely without immunosuppressive agents, despite incompatibility between donor and recipient for antigens of the major histocompatibility complex. This is strain-dependent. In the DA to PVG strain combination, liver grafts are never rejected. This is not due to failure of the recipient to mount an immune response against the donor tissue, because there is unequivocal histological evidence of a rejection response during the first few weeks after grafting. This response is moderate and disappears to leave a histologically normal liver, apart from mild bile duct proliferation. Liver function tests show evidence of damage during the phase of cellular infiltration, but these test results also return to normal levels within a few weeks. In the DA to BN strain combination liver grafts are rapidly rejected, and this process is accompanied by histological signs of a violent and progressive destructive cellular response with gross alterations in liver function test results that are progressive until the death of the recipients. F1 hybrid recipients between these two strains (BN X PVG)F1 show intermediate levels of both histological damage and elevated liver function values, but they do not reject their grafts. Recovery from the rejection episode appears to be complete, as judged histologically. However, biochemical values remain slightly elevated, indicating either that the original damage was so severe that it was inconsistent with complete functional recovery or that there is continuous damage that is not visible histologically.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404027

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  Immunological tolerance induced by liver grafting in the rat: splenic macrophages and T cells mediate distinct phases of immunosuppressive activity.

Authors:  S Yoshimura; S Gotoh; N Kamada
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Fibronectin-α4β1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway.

Authors:  S Duarte; X-D Shen; C Fondevila; R W Busuttil; A J Coito
Journal:  Am J Transplant       Date:  2012-07-19       Impact factor: 8.086

Review 3.  The immunology of experimental liver transplantation in the rat.

Authors:  N Kamada
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

4.  Transfer of specific immunosuppression of graft rejection using lymph from tolerant liver-grafted rats.

Authors:  N Kamada
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

5.  Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.

Authors:  S Qian; L Lu; F Fu; Y Li; W Li; T E Starzl; J J Fung; A W Thomson
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

Review 6.  In search of the Holy Grail (actively acquired immunologic tolerance).

Authors:  J C McDonald
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

Review 7.  Current status of intestinal transplantation.

Authors:  S Todo; A Tzakis; K Abu-Elmagd; J Reyes; T E Starzl
Journal:  Adv Surg       Date:  1994

8.  Hepatocellular metabolic change after orthotopic liver transplantation in rats.

Authors:  Y Nakajima; J Kimura; J Uchino; W Isselhard; J H Fischer
Journal:  Jpn J Surg       Date:  1991-01

9.  Split tolerance induced by orthotopic liver transplantation in mice.

Authors:  U Dahmen; S Qian; A S Rao; A J Demetris; F Fu; H Sun; L Gao; J J Fung; T E Starzl
Journal:  Transplantation       Date:  1994-07-15       Impact factor: 4.939

10.  Cyclosporine and partial liver allotransplants in a simplified rat model.

Authors:  S Inoue; N Kawano; Y Morioka
Journal:  Jpn J Surg       Date:  1985-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.